Receipt of NDA Approval of Alesion LX for anti-allergy in Japan, and Joint Sales Promotion Contract with Mitsubishi Tanabe Pharma Posted Sep 20, 2019
Sponsorship Agreement for IBSA Blind Football Asian Championships 2019 signed between Santen, IBF Foundation, and JBFA Posted Sep 6, 2019
Santen Announces Topline Pivotal Data for DE-128 (MicroShunt) Demonstrating Reductions in Intraocular Pressure and Medication Use in Patients Posted Aug 30, 2019
Notice on the Completion of Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program Posted Jul 24, 2019
R&D collaboration and Option & Licence Agreement with Oxford Biomedica for development of gene therapy vectors for inherited retinal disease Posted Jun 26, 2019
Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program Posted Jun 25, 2019
Santen Chooses SAP S/4HANA Cloud and Other SAP Solutions to Reform Key Operation System and Strengthen Global Management Structure Posted Jun 11, 2019
Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United States Posted Apr 26, 2019
Santen Announces Launch of LENTIS Comfort, Low-Add Segmental Intraocular Lens for Cataract Treatment in Japan Posted Apr 18, 2019
Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16 Posted Mar 8, 2019
Santen Selected and Launches Photo-Crosslinking Research and Development Project for Pathologic Myopia Treatment for CiCLE Program Posted Mar 6, 2019
Santen Selected and Launches Gene Therapy Drug Research and Development Project for Inherited Ocular Disease Treatment for CiCLE Program Posted Mar 6, 2019
Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma Week in March Posted Jan 31, 2019
